Fujisawa Pharmaceutical
Executive Summary
Jon Kaeuper to join later in June as VP-marketing responsible for the marketing organization of the former Lyphomed ethical drug and Fujisawa/SmithKline units, which were combined in April ("The Pink Sheet" April 9, T&G-7). Kaeuper joins from SmithKline Beecham, where he was VP-Anti-infective/Cardiovascular Product Group-U.S. Cynthia Yost of Lyphomed reports to Kaeuper as the new director of marketing. She joined Lyphomed two years ago from Bristol-Myers.